Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: A pathological study

The Lancet Oncology

Volumn 13, Issue 6, 2012, Pages 598-606

  Kloor, Matthias ^a,b   Huth, Cathrin ^a,b   Voigt, Anita Y ^a,b   Benner, Axel ^b   Schirmacher, Peter ^a   von Knebel Doeberitz, Magnus ^a,b   Bläker, Hendrik ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; MISMATCH REPAIR PROTEIN; PROTEIN MLH1; PROTEIN MSH2;

APC GENE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE INACTIVATION; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; LARGE INTESTINE CANCER; MICROSATELLITE INSTABILITY; MISMATCH REPAIR GENE; PATHOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE CANCER;

ABERRANT CRYPT FOCI; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PARAFFIN EMBEDDING; POISSON DISTRIBUTION; PREVALENCE; REFERENCE VALUES;

EID: 84861579932     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70109-2     Document Type: Article

References (44)

1. de la Chapelle A Microsatellite instability. N Engl J Med 2003, 349:209-210.
2. Ligtenberg MJ, Kuiper RP, Chan TL, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet 2009, 41:112-117.
3. Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996, 56:4836-4840.
4. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002, 20:1043-1048.
5. Quehenberger F, Vasen HF, van Houwelingen HC Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 2005, 42:491-496.
6. Engel C, Rahner N, Schulmann K, et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 2010, 8:174-182.
7. Liljegren A, Barker G, Elliott F, et al. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. J Clin Oncol 2008, 26:3434-3439.
8. Lindgren G, Liljegren A, Jaramillo E, Rubio C, Lindblom A Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 2002, 50:228-234.
9. de Jong AE, Morreau H, van PM, et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 2004, 126:42-48.
10. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991, 22:287-294.
11. Takayama T, Ohi M, Hayashi T, et al. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001, 121:599-611.
12. Fearon ER Molecular genetics of colorectal cancer. Annu Rev Pathol 2011, 6:479-507.
13. Giuffre G, Muller A, Brodegger T, et al. Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis. J Mol Diagn 2005, 7:160-170.
14. Pino MS, Mino-Kenudson M, Wildemore BM, et al. Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. J Mol Diagn 2009, 11:238-247.
15. de la Chapelle A, Hampel H Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 2010, 28:3380-3387.
16. Lynch HT, Smyrk T, Jass J.R. Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas?. Semin Surg Oncol 1995, 11:406-410.
17. Rijcken FE, Hollema H, Kleibeuker JH Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 2002, 50:382-386.
18. Kloor M, Sutter C, Wentzensen N, et al. A large MSH2 Alu insertion mutation causes HNPCC in a German kindred. Hum Genet 2004, 115:432-438.
19. Findeisen P, Kloor M, Merx S, et al. T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 2005, 65:8072-8078.
20. Woerner SM, Kloor M, Mueller A, et al. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene 2005, 24:2525-2535.
21. R: a language and environment for statistical computing 2011, R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria.
22. Gupta AK, Schoen RE Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?. Curr Opin Gastroenterol 2009, 25:59-65.
23. Alrawi SJ, Schiff M, Carroll RE, et al. Aberrant crypt foci. Anticancer Res 2006, 26:107-119.
24. Smith AJ, Stern HS, Penner M, et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994, 54:5527-5530.
25. Heinen CD, Shivapurkar N, Tang Z, Groden J, Alabaster O Microsatellite instability in aberrant crypt foci from human colons. Cancer Res 1996, 56:5339-5341.
26. Augenlicht LH, Richards C, Corner G, Pretlow TP Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 1996, 12:1767-1772.
27. Pedroni M, Sala E, Scarselli A, et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 2001, 61:896-899.
28. Greenspan EJ, Cyr JL, Pleau DC, et al. Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis 2007, 28:769-776.
29. Kloor M, Voigt AY, Schackert HK, Schirmacher P, von Knebel Doeberitz M, Blaker H Analysis of EPCAM protein expression in diagnostics of Lynch syndrome. J Clin Oncol 2011, 29:223-227.
30. Parsons R, Li GM, Longley M, et al. Mismatch repair deficiency in phenotypically normal human cells. Science 1995, 268:738-740.
31. Dietmaier W, Gansbauer S, Beyser K, et al. Microsatellite instability in tumor and nonneoplastic colorectal cells from hereditary non-polyposis colorectal cancer and sporadic high microsatellite-instable tumor patients. Pathobiology 2000, 68:227-231.
32. Marshman E, Booth C, Potten CS The intestinal epithelial stem cell. Bioessays 2002, 24:91-98.
33. Bjerknes M, Cheng H Colossal crypts bordering colon adenomas in Apc(Min) mice express full-length Apc. Am J Pathol 1999, 154:1831-1834.
34. Humphries A, Wright NA Colonic crypt organization and tumorigenesis. Nat Rev Cancer 2008, 8:415-424.
35. Simons BD, Clevers H Stem cell self-renewal in intestinal crypt. Exp Cell Res 2011, 317:2719-2724.
36. Grady WM, Rajput A, Myeroff L, et al. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 1998, 58:3101-3104.
37. de la Chapelle A, Hampel H Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 2010, 28:3380-3387.
38. Boland CR, Goel A Microsatellite instability in colorectal cancer. Gastroenterology 2010, 138:2073-2087.
39. Shibata D When does MMR loss occur during HNPCC progression?. Cancer Biomark 2006, 2:29-35.
40. Saeterdal I, Bjorheim J, Lislerud K, et al. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 2001, 98:13255-13260.
41. Schwitalle Y, Kloor M, Eiermann S, et al. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 2008, 134:988-997.
42. Reuschenbach M, Kloor M, Morak M, et al. Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome. Fam Cancer 2010, 9:173-179.
43. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002, 3:991-998.
44. Czéh M, Loddenkemper C, Shalapour S, et al. The immune response to sporadic colorectal cancer in a novel mouse model. Oncogene 2010, 29:6591-6602.